Seikagaku Obtains Favorable Results from PIII Study of Condoliase for Lumbar Disc Herniation, Plans to File NDA in Japan During FY2013

Seikagaku Corporation announced on August 7 that it has obtained favorable results from a PIII clinical study of its investigational lumbar disc herniation treatment SI-6603 (condoliase) in Japan. Based on the results from the study, the company aims to file...read more